{
    "Trade/Device Name(s)": [
        "Diazyme Creatinine Liquid Reagents Assay",
        "Diazyme Creatinine Control"
    ],
    "Submitter Information": "Diazyme Laboratories",
    "510(k) Number": "k062105",
    "Predicate Device Reference 510(k) Number(s)": [
        "k003261",
        "k063206"
    ],
    "Regulatory Class": "Class II (Enzymatic Method, Creatinine); Class I (Single (specified) analyte controls (assayed and unassayed))",
    "Product Code(s)": [
        "JFY",
        "JJX"
    ],
    "Summary Letter Date": "April 23, 2007",
    "Summary Letter Received Date": "March 21, 2007",
    "Submission Date": "March 19, 2007",
    "Regulation Number(s)": [
        "862.1225",
        "862.1660"
    ],
    "Regulation Name(s)": [
        "Creatinine Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatinine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Kinetic assay",
        "Absorbance measurement at 550 nm"
    ],
    "Methodologies": [
        "Coupled enzymatic reactions (creatininase, creatinase, sarcosine oxidase, peroxidase)"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Calibrator",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme Creatinine Liquid Reagents Assay and Control, an enzymatic in vitro assay for creatinine quantitation in serum and urine.",
    "Indications for Use Summary": "Quantitative determination of creatinine in serum and urine for diagnosis and treatment of renal diseases, monitoring renal dialysis, and as a calculation basis for measuring other urine analytes; control intended as a reference sample for monitoring the assay.",
    "fda_folder": "Clinical Chemistry"
}